The HER2-positive gastric cancer market focuses on targeted therapies and diagnostics used to treat gastric cancers that overexpress the HER2 protein. Growth is driven by increasing gastric cancer incidence, improved biomarker testing, and adoption of HER2-targeted drugs that enhance treatment efficacy. Precision medicine approaches and combination therapies are improving survival out... https://www.databridgemarketresearch.com/reports/global-her2-gastric-cancer-market